Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @CDCgov: Last #flu season, nearly a million people were hospitalized and about 79,000 people died from flu. Get your flu vac… https://t.co/nUHlZ6pr1G
SteveFDA (R-D.C.)
@SGottliebFDA
Don't risk your eyesight trying to perfect your #Halloween costume. Decorative contact lenses require a prescription https://t.co/IJRaSZJAaV https://t.co/OFh2cMIGWz
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_ORA: #TBT: WATCH this video to learn about the tools that FDA regulators use to keep pace w/the changes in commodities.… https://t.co/Hv539XFLr2
SteveFDA (R-D.C.)
@SGottliebFDA
Changing drug treatment based on the results from such a genetic test could lead to inappropriate treatment decisions and potentially serious health consequences for the patient.
SteveFDA (R-D.C.)
@SGottliebFDA
FDA ALERT: Safety Communication - The #FDA Warns Against the use of Many Genetic Tests with Unapproved Claims to Predict Patient Response to Specific Medications: https://t.co/74gqcUNUV4 https://t.co/YsmxSI6Dtz
SteveFDA (R-D.C.)
@SGottliebFDA
= USDA. = FDA. QT @NY1: The #MandarinDuck was spotted again today in @CentralParkNYC and he's gaining quite a bit of attention. 🦆📸 https://t.co/GKVp5rMuNE)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @frankyiannas: FDA Commissioner Gottlieb said efforts hampered because “majority of the records collected in this investigation we… https://t.co/K37kLB7MRO
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: New draft guidance we’ve issued today provides recommendations to spur drug development for chronic hep B infection https://t.co/tYVujHdNUI
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: Have you been told you have a variant of uncertain significance in a gene on #genetictesting? It might be worth che… https://t.co/kn0uDDXKkb
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: FDA Commissioner @SGottliebFDA on findings from the romaine lettuce E. coli O157:H7 outbreak investigation and FDA’… https://t.co/P7R7aOQT43
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: Smoking causes chronic obstructive pulmonary disease, otherwise known as COPD. COPD robs the lungs of air and can l… https://t.co/aD3ZApJRA4
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: Cybersecurity is among the FDA’s top priorities for protecting and promoting public health. Read the latest… https://t.co/ePvOY2m9TJ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @PharmaPinkSheet: US FDA Mulling Core Criteria For Patient-Reported Outcomes https://t.co/sdk6qVVGxh #PinkSheet
SteveFDA (R-D.C.)
@SGottliebFDA
We should consider whether we could do more in weighing approvals to ensure that new opioids are sufficiently better than existing drugs to justify their addition to the market in the context of the current crisis of abuse.
SteveFDA (R-D.C.)
@SGottliebFDA
We’ll consider whether we should be doing more to evaluate each new opioid, not just as an independent review decision, but rather also to consider each novel opioid in the context of the overall therapeutic armamentarium available to patients, providers. https://t.co/NICWpF4Uri
SteveFDA (R-D.C.)
@SGottliebFDA
As we look at the public health implications of each new approval, we should evaluate whether we need to take additional steps to systematically consider new opioids relative to the comparative benefit and risks of other opioid drugs that are already on the market.
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAJobs: FDA is honored to announce the kick off of the Veterans Viewpoint, a virtual recruitment effort dedicated to servi… https://t.co/7AeJfuUy0l
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAMedia: FDA issues new guidances to help manufacturers continue implementing updated Nutrition Facts label https://t.co/CqkYnQiKRa
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA is evaluating a new framework for opioid approvals to define how we’ll consider benefit and risk of these products in the context of the public health crisis and, specifically, how we weigh new approvals against the overall therapeutic armamentarium https://t.co/NICWpF4Uri https://t.co/6otKpLctb2
SteveFDA (R-D.C.)
@SGottliebFDA
RT @steveusdin1: In the wake of calls for FDA to reject a new opioid analgesic, @SGottliebFDA explained the agency’s decision to ap… https://t.co/wJ5MOxwWOn